# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Reneo Pharmaceuticals (NASDAQ:RPHM) reported quarterly losses of $(0.70) per share which missed the analyst consensus estimate ...
Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an ac...
Shares of Ascent Industries Co. (NASDAQ: ACNT) rose sharply in pre-market trading as the company reported the sale of the busi...
Concentra Biosciences, LLC4747 Executive Drive, Suite 210 | San Diego, CA 92121December 26, 2023Board of DirectorsReneo Pharmac...
HC Wainwright & Co. analyst Mitchell Kapoor downgrades Reneo Pharmaceuticals (NASDAQ:RPHM) from Buy to Neutral and lower...
Jefferies analyst Eun Yang downgrades Reneo Pharmaceuticals (NASDAQ:RPHM) from Buy to Hold and lowers the price target from ...
Leerink Partners analyst Joseph Schwartz downgrades Reneo Pharmaceuticals (NASDAQ:RPHM) from Outperform to Market Perform an...